Digital Health Roundup, July 2021: Exec Chat With DTA, Start-Ups Grab New Funds, Agency Nods
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.
You may also be interested in...
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.
The UK-based company said it will use the new funding to advance commercialization of its daytime treatment for mild sleep apnea and snoring.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.